386 related articles for article (PubMed ID: 22513793)
21. High dose consolidation with autologous stem cell rescue (ASCR) for nephroblastoma initially treated according to the SIOP 9/GPOH trial and study.
Hempel L; Kremens B; Weirich A; Graf N; Zintl F; Ludwig R
Klin Padiatr; 1996; 208(4):186-9. PubMed ID: 8776705
[TBL] [Abstract][Full Text] [Related]
22. Clear cell sarcoma of the kidney: patients' characteristics and improved outcome in developing countries.
Zekri W; Alfaar AS; Yehia D; Elshafie MM; Zaghloul MS; El-Kinaai N; Taha H; Refaat A; Younes AA
Pediatr Blood Cancer; 2014 Dec; 61(12):2185-90. PubMed ID: 25175045
[TBL] [Abstract][Full Text] [Related]
23. How to improve initial diagnostic accuracy of kidney tumours in childhood?-A non-invasive approach.
Welter N; Metternich G; Furtwängler R; Bayoumi A; Mergen M; Kager L; Vokuhl C; Warmann SW; Fuchs J; Meier CM; Melchior P; Gessler M; Wagenpfeil S; Schenk JP; Graf N
Int J Cancer; 2024 Jun; 154(11):1955-1966. PubMed ID: 38319190
[TBL] [Abstract][Full Text] [Related]
24. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
Stefanowicz J; Sierota D; Balcerska A; Stoba C
Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
[TBL] [Abstract][Full Text] [Related]
25. Partial nephrectomy for unilateral Wilms tumor: results of study SIOP 93-01/GPOH.
Haecker FM; von Schweinitz D; Harms D; Buerger D; Graf N
J Urol; 2003 Sep; 170(3):939-42; discussion 943-4. PubMed ID: 12913746
[TBL] [Abstract][Full Text] [Related]
26. [Late results of the complex treatment of primary kidney neoplasm in children].
Minkov N; Christosova I; Kiourktchieva S; Rousseva T
Ann Urol (Paris); 1997; 31(6-7):344-7. PubMed ID: 9509234
[TBL] [Abstract][Full Text] [Related]
27. Surgical complications in the treatment of Wilms' tumor.
Stehr M; Deilmann K; Haas RJ; Dietz HG
Eur J Pediatr Surg; 2005 Dec; 15(6):414-9. PubMed ID: 16418959
[TBL] [Abstract][Full Text] [Related]
28. Outcome of relapses of nephroblastoma in patients registered in the SIOP/GPOH trials and studies.
Reinhard H; Schmidt A; Furtwängler R; Leuschner I; Rübe C; Von Schweinitz D; Zoubek A; Niggli F; Graf N
Oncol Rep; 2008 Aug; 20(2):463-7. PubMed ID: 18636212
[TBL] [Abstract][Full Text] [Related]
29. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
30. Treatment of recurrent clear cell sarcoma of the kidney with brain metastasis.
Radulescu VC; Gerrard M; Moertel C; Grundy PE; Mathias L; Feusner J; Diller L; Dome JS
Pediatr Blood Cancer; 2008 Feb; 50(2):246-9. PubMed ID: 17226850
[TBL] [Abstract][Full Text] [Related]
31. Mesoblastic nephroma--a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH).
Furtwaengler R; Reinhard H; Leuschner I; Schenk JP; Goebel U; Claviez A; Kulozik A; Zoubek A; von Schweinitz D; Graf N;
Cancer; 2006 May; 106(10):2275-83. PubMed ID: 16596620
[TBL] [Abstract][Full Text] [Related]
32. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
33. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
[TBL] [Abstract][Full Text] [Related]
34. Non-Wilms' renal tumors in children: experience with 139 cases treated at a single center.
Fang YW; Song HC; Sun N; Zhang WP
BMC Urol; 2022 Jun; 22(1):89. PubMed ID: 35733141
[TBL] [Abstract][Full Text] [Related]
35. [Resection of nephroblastoma: problems and complications--evaluation of the Nephroblastoma Study SIOP 9/GPOH].
Roth H; Weirich A; Ludwig R; Daum R; Zimmermann H
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1078-83. PubMed ID: 9101785
[TBL] [Abstract][Full Text] [Related]
36. Clear cell sarcoma: a dilemma on pathological staging and clinical management.
Ng A; Jenkinson H; Morland B; Grundy R
Pediatr Hematol Oncol; 2005; 22(3):257-61. PubMed ID: 16020110
[TBL] [Abstract][Full Text] [Related]
37. Treatment of cystic nephroma and cystic partially differentiated nephroblastoma--a report from the SIOP/GPOH study group.
Luithle T; Szavay P; Furtwängler R; Graf N; Fuchs J;
J Urol; 2007 Jan; 177(1):294-6. PubMed ID: 17162067
[TBL] [Abstract][Full Text] [Related]
38. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
39. Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients.
Wu PK; Chen WM; Chen CF; Lee OK; Haung CK; Chen TH
Jpn J Clin Oncol; 2009 Aug; 39(8):514-22. PubMed ID: 19525290
[TBL] [Abstract][Full Text] [Related]
40. A 20-year prospective study of Wilms tumor and other kidney tumors: a report from Hong Kong pediatric hematology and oncology study group.
Chan CC; To KF; Yuen HL; Shing Chiang AK; Ling SC; Li CH; Cheuk DK; Li CK; Shing MM
J Pediatr Hematol Oncol; 2014 Aug; 36(6):445-50. PubMed ID: 25050908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
